ArticleBiological trace element research2026
Efficacy of Bacopa monnieri in Mitigating Lead-Induced Blood Toxicity in Swiss Albino Mice Compared to Synthetic Antioxidants.
Article in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The major objective of the current study is to investigate the protective and therapeutic potential of Bacopa monnieri extract and synthetic antioxidants (N-acetyl cysteine, ascorbic acid, tocopheryl acetate, and thiamine mixture) against lead-induced hematological toxicity in Swiss albino mice. HPLC analysis of the ethanolic extract of Bacopa monnieri (B. monnieri) revealed a rich profile of bioactive compounds, including flavonoids like apigenin and luteolin, bacosides, and bacopasaponins. In vivo experiments demonstrated dose-dependent statistically significant (p < 0.001) hematological alterations in lead-exposed groups, showing reductions in hemoglobin (Hb), red blood cell (RBC) count, platelet count, hematocrit, mean corpuscular volume (MCV), and mean corpuscular hemoglobin (MCH), alongside an increase in white blood cell (WBC) count as compared to the control, indicating severe hematotoxic effects of lead. In synergistic study groups, co-administration of lead acetate with synthetic antioxidants or B. monnieri extract conferred protection against lead-induced toxicity by mitigating alterations in hematological parameters of Hb, RBC, WBC, and platelet count, with a more pronounced effect of B. monnieri than synthetic antioxidants. Curative study groups further demonstrated restoration of hematological parameters near the control group baseline, highlighting the superior efficacy of B. monnieri in reversing lead-induced toxicity. In conclusion, the findings of the study imply that the herbal antioxidant B. monnieri has better potential to be an effective ameliorative therapeutic agent against lead-induced hematological toxicity as compared to synthetic antioxidants, which may be attributed to the presence of plentiful phytochemicals in its extract that can be employed effectively for the development of plant-based therapies for the eradication of lead poisoning in endemic regions.
Indexed as
Identifiers
41193727What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.